Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: A clinical perspective and emerging treatment options

Elias J. Jabbour, Jorge E. Cortes, Hagop M. Kantarjian

Research output: Contribution to journal › Review article › peer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Resistance to tyrosine kinase inhibition therapy for chronic myelogenous leukemia: A clinical perspective and emerging treatment options'. Together they form a unique fingerprint.

Medicine & Life Sciences